Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2016

01-08-2016 | Retraction Note

Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways

Authors: Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Raza Ali, Shadan Ali, Sanjeev Banerjee, Fazlul H. Sarkar

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Excerpt

The paper is retracted at the request of the publisher because blots of Figs. 3c and 5a were manipulated and compiled from different films without explanation. …
Metadata
Title
Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
Authors
Aamir Ahmad
Zhiwei Wang
Dejuan Kong
Raza Ali
Shadan Ali
Sanjeev Banerjee
Fazlul H. Sarkar
Publication date
01-08-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3905-x

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine